These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 14626984

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Drug manufacturers' First Amendment right to advertise and promote their products for off-label use: avoiding a pyrrhic victory.
    Blackwell AE, Beck JM, Dechert, L.L.P, Philadelphia, USA.
    Food Drug Law J; 2003; 58(3):439-62. PubMed ID: 14626985
    [No Abstract] [Full Text] [Related]

  • 3. The First Amendment and the Food and Drug Administration's regulation of labeling and advertising: three proposed reforms.
    Kahan JS, Shapiro JK.
    Food Drug Law J; 2003; 58(3):353-64. PubMed ID: 14626983
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The First Amendment and federal court deference to the Food and Drug Administration: The Times They Are A-Changin'.
    Basile EM, Gross M.
    Food Drug Law J; 2004; 59(1):31-44. PubMed ID: 15190924
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Education or promotion?: Industry-sponsored continuing medical education (CME) as a center for the core/commercial speech debate.
    Chen P, Paul, Weiss, Rifkind, Wharton & Garrison LLP, New York, NY, USA.
    Food Drug Law J; 2003; 58(3):473-509. PubMed ID: 14626981
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The ongoing dialogue between the Food and Drug Administration and the Federal Trade Commission.
    Leary TB.
    Food Drug Law J; 2004; 59(2):209-15. PubMed ID: 15318392
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Direct-to-consumer prescription drug advertising.
    Terzian TV.
    Am J Law Med; 1999; 25(1):149-67. PubMed ID: 10207573
    [No Abstract] [Full Text] [Related]

  • 17. Market exclusivity after a prescription to nonprescription drug switch: striking the right balance between innovation and competition.
    Kraushaar KJ.
    Food Drug Law J; 1999; 54(2):243-4. PubMed ID: 11758581
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.